Skip to main content

Ototoxicity clinical trials at UC Health
1 in progress, 0 open to eligible people

  • Treatment of Radiation and Cisplatin Induced Toxicities With Tempol

    Sorry, not yet accepting patients

    A 10 week trial to assess the ability of Tempol to prevent and/or reduce toxicities associated with cisplatin and radiation treatment in head and neck cancer patients. Over the course of the 10 week trial, mucositis, nephrotoxicity, and ototoxicity will be monitored and assessed.

    at UCSD

Last updated: